U.S. Stock News

NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide Delivers C¥314 Million Q4 Revenue As Investors Weigh Path To Profitability

WeRide (NasdaqGM:WRD) has capped FY 2025 with fourth quarter revenue of C¥314 million and a basic EPS loss of C¥1.71, while trailing twelve month figures show revenue of C¥684.6 million and a net income loss of C¥1.65 billion. Over recent quarters, the company has seen revenue move from C¥70.0 million and a basic EPS loss of C¥14.79 in Q3 2024 to C¥140.8 million with a C¥2.43 loss per share in Q4 2024, then to C¥72.4 million and a C¥1.27 loss in Q1 2025 before reaching C¥314 million in Q4...
NYSE:FLUT
NYSE:FLUTHospitality

US Bill Targeting Prediction Markets Puts Flutter’s US Story In Focus

A bipartisan group of US senators has introduced a bill to restrict prediction markets from offering sports betting style contracts and casino type products. The proposal targets platforms such as Kalshi and Polymarket, which currently sit outside the traditional US sports betting regulatory framework. If enacted, the bill would tighten the rules around unregulated competitors to licensed sportsbooks, including Flutter Entertainment's US operations. Flutter Entertainment (NYSE:FLUT),...
NYSE:FR
NYSE:FRIndustrial REITs

Is First Industrial Realty Trust (FR) Pricing Reflect Its Position In Industrial Real Estate Today

If you are wondering whether First Industrial Realty Trust at around US$58.06 is offering fair value or not, this article walks through what the current data suggests about the price you see on screen. The stock has recently been mixed, with a 4.8% decline over the last 7 days and a 6.5% decline over 30 days, even though returns stand at 0.3% year to date and 10.7% over 1 year, 24.3% over 3 years, and 42.2% over 5 years. Recent news flow around First Industrial Realty Trust has focused on...
NYSE:UAMY
NYSE:UAMYMetals and Mining

Is It Too Late To Consider United States Antimony (UAMY) After Its Recent Surge In Price?

If you are wondering whether United States Antimony at US$8.94 still offers value after a big run, this breakdown is designed to help you frame that question clearly. The stock shows a 300.9% return over the last year and a very large 3 year gain of 2,267.6%. At the same time, the 7 day return of an 18.6% decline and the 30 day return of 21.0% highlight recent volatility on top of a 50.8% year to date move. This price action has drawn more attention to United States Antimony, with investors...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Caledonia Mining (NYSEAM:CMCL) Earnings Surge To 21.9% Margin Challenges Cautious Narratives

Caledonia Mining (NYSEAM:CMCL) has put up a busy FY 2025 so far, with Q3 revenue of US$68.0 million and basic EPS of US$0.77, sitting within a trailing 12 month backdrop where earnings grew by a very large 917.5% and the net profit margin reached 21.9% versus 3% a year earlier. Over recent quarters the company has seen revenue move from US$45.1 million in Q4 2024 to US$53.4 million in Q1 2025, US$61.8 million in Q2 2025 and US$68.0 million in Q3 2025. Quarterly basic EPS shifted from US$0.25...
NasdaqGS:ABUS
NasdaqGS:ABUSBiotechs

Arbutus Biopharma (ABUS) Q3 Loss And Revenue Drop Challenge Bullish Profitability Narratives

Arbutus Biopharma FY 2025 Earnings Snapshot Arbutus Biopharma (ABUS) has turned in a mixed FY 2025 readout so far, with Q3 total revenue at US$0.5 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of US$14.6 million and a basic EPS loss of US$0.22. Over recent quarters, the company has reported revenue in a range between US$0.5 million and US$10.7 million per quarter, while quarterly basic EPS has ranged from a loss of US$0.13 to a profit of US$0.01. This gives...
NYSE:JBL
NYSE:JBLElectronic

Jabil Backs St Petersburg College To Support Future Manufacturing Talent

Jabil (NYSE:JBL) has committed $1.1 million over multiple years to support advanced manufacturing training at St. Petersburg College. The partnership will fund scholarships, upgrade manufacturing curriculum, and expand access to advanced technology for students in the Tampa Bay region. This initiative is aimed at developing a stronger local manufacturing talent pipeline and deepening Jabil's community engagement. For investors tracking NYSE:JBL, this move comes with the stock at a share...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

Is It Time To Reassess Patria Investments (PAX) After Its Recent Share Price Weakness?

If you are wondering whether Patria Investments is starting to look like value at around US$11.51, the next step is to see how that price compares with what the business might be worth. The stock has had a mixed run, with a 1.1% gain over the last 7 days, a 17.8% decline over the past 30 days, and a 27.7% decline year to date, while the 1 year return sits at 2.0% and the 3 and 5 year returns are 5.7% and 11.3% declines respectively. Those swings have put valuation firmly in focus for many...
NYSE:BALY
NYSE:BALYHospitality

Bally’s (BALY) Heavy Q3 Loss Of US$102.9 Million Reinforces Bearish Profitability Narratives

Bally's (BALY) FY 2025 earnings snapshot Bally's (BALY) latest FY 2025 update centers on Q3 numbers, with revenue of US$663.7 million, a basic EPS loss of US$1.70, and net income loss of US$102.9 million as the company continues to operate in the red. Over recent quarters, revenue has ranged from US$580.4 million in Q4 2024 to US$663.7 million in Q3 2025, while quarterly basic EPS has moved between a loss of US$0.30 and a loss of US$5.10, underscoring pressure on profitability. For investors,...
NYSEAM:IDR
NYSEAM:IDRMetals and Mining

Idaho Strategic Resources (IDR) 29% Net Margin Reinforces Bullish Earnings Quality Narrative

Idaho Strategic Resources (IDR) has put up another solid set of numbers for FY 2025 so far, with third quarter revenue at about US$11.1 million, basic EPS of US$0.20 and trailing 12 month EPS of US$0.73 underpinning net income of US$10.27 million over the past year. The company has seen revenue step up from US$6.2 million in Q2 FY 2024 to US$7.6 million in Q4 FY 2024 and then to US$11.1 million in Q3 FY 2025. Quarterly basic EPS moved from US$0.17 to US$0.18 and now just over US$0.20, setting...
NYSE:TK
NYSE:TKOil and Gas

Should Teekay’s (TK) Softer 2025 Earnings and EPS Compression Require Action From Investors?

Teekay Corporation Ltd. has reported past full-year 2025 results, with sales of US$949.52 million and net income of US$98.11 million, both lower than the prior year. The decline in basic earnings per share from continuing operations, from US$1.47 to US$1.14, underscores pressure on Teekay’s underlying profitability. With earnings showing reduced revenue and profit, we’ll examine how this softer performance shapes Teekay’s investment narrative going forward. The latest GPUs need a type of...
NasdaqCM:LIDR
NasdaqCM:LIDRElectronic

Assessing AEye (LIDR) Valuation After NVIDIA Halos Partnership And Mixed 2025 Earnings

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...
NYSE:MDU
NYSE:MDUGas Utilities

Is It Time To Reassess MDU Resources Group (MDU) After Recent Share Price Pullback

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Has The AI Hardware Pullback Created A New Entry Point In Astera Labs (ALAB)?

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

SS Innovations (SSII) Is Up 10.8% After Southeast Asia Telesurgery Approvals And Revenue Jump – What's Changed

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Performance

Recent stock performance and what it might signal Tyra Biosciences (TYRA) has drawn attention after a 2.7% decline in the last session, following a sharp move over the past 3 months that left the stock up 46.4%. Over the past month the shares are up 17.6%, while the 1 year total return stands at 247.5%, set against a recent closing price of US$37.15 and a market value of about US$2.0b. See our latest analysis for Tyra Biosciences. Put simply, Tyra Biosciences has combined sharp short term...
NYSE:DAY
NYSE:DAYProfessional Services

Assessing Dayforce (DAY) Valuation After Expanded Emburse And DocuSign Partnerships

What the Emburse and DocuSign expansions mean for Dayforce stock Dayforce (DAY) has broadened its relationships with Emburse and DocuSign, folding expense management and digital agreement tools more tightly into its HCM platform through certified integrations and a reseller model. For you as an investor, this move centers on two practical ideas: Dayforce aiming to keep more of a customer’s HR workflow inside its own ecosystem, and partners gaining distribution through Dayforce’s channel. See...
NYSE:D
NYSE:DIntegrated Utilities

Dominion Energy Faces Governance Push As Valuation Signals Mixed Outlook

Shareholders at Dominion Energy (NYSE:D) have filed several proposals ahead of the upcoming annual meeting focused on board independence and governance reforms. Key items include calls to separate the CEO and Chair roles, tie executive pay to ESG and DEI metrics, and expand mechanisms for shareholder engagement. The company has recommended that investors vote against these proposals, setting up a clear point of tension between management and some shareholder groups. Dominion Energy, a major...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group (CSGP) Attractive After A 45% One-Year Share Price Slide?

If you are wondering whether CoStar Group at US$42.90 is starting to look interesting on price alone, the recent share performance gives plenty to think about. The stock has declined 1.7% over the past week, 14.0% over the past month, and is down 34.7% year to date and 45.3% over the last year, which may suggest that the market is reassessing its expectations and risk appetite around the company. These moves sit against a backdrop where investors have been reacting to ongoing sector...
NasdaqGS:HUMA
NasdaqGS:HUMABiotechs

A Look At Humacyte (HUMA) Valuation As Symvess Secures Saudi Commitment And Israel Filing

Interest in Humacyte (HUMA) is being shaped by a US$1.475 million minimum purchase commitment for Symvess in Saudi Arabia, along with a Marketing Authorization Application in Israel, both focused on vascular trauma treatment. See our latest analysis for Humacyte. The recent Saudi Arabia purchase commitment and Israel filing come at a time when Humacyte's share price return has moved sharply, with a 7 day share price return of 32.51% and a 1 year total shareholder return of 76.42%, suggesting...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu Board Changes Raise Questions On Governance And AI Oversight

Baidu (NasdaqGS:BIDU) announced the resignation of Mr. James Ding as an independent director. Mr. Ding also stepped down as chairman of Baidu's compensation committee. The change affects the composition and leadership of Baidu's board-level oversight. Baidu operates as a major internet and AI company in China, with businesses that span search, online marketing and cloud services. For investors, board composition matters because it shapes how executive pay, risk controls and long term...
NYSE:AERO
NYSE:AEROAirlines

Grupo Aeroméxico ESOP Shelf Filing Meets Low Valuation And Weak Momentum

Grupo Aeroméxico (NYSE:AERO) has filed a substantial shelf registration tied to an employee stock ownership plan. The registration relates to future issuance of shares to employees under the ESOP framework. The move signals a fresh phase in the company’s capital planning and workforce incentive approach. Grupo Aeroméxico, listed as NYSE:AERO, operates as Mexico’s flagship airline with a focus on passenger and cargo services. The new ESOP related shelf registration arrives at a time when...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Is It Too Late To Consider Pharvaris (PHVS) After A 3.5x Three Year Surge?

If you are wondering whether Pharvaris at around US$26 a share still offers value, it helps to step back and look at what the recent returns and current valuation are really telling you. The stock has delivered a 68.8% return over the past year and a very large 3 year gain of around 3.5x, even though the year to date return is a 1.8% decline and the 30 day return is a 7.5% decline. This can change how the risk and reward balance feels right now. Recent headlines around Pharvaris have focused...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Coastal Financial Adds Fintech Veteran As Shares Trade Below Targets

Coastal Financial (NasdaqGS:CCB) has appointed Jeffrey M. Chapman, a banking technology veteran with over 25 years of experience, to its Board of Directors. Chapman will serve on the Technology and CCBX Oversight Committees, with the appointment highlighting a focus on digital banking and platform development. Coastal Financial, trading at $74.36, has seen a mixed share price record, with a 103.6% return over 3 years and a 176.9% return over 5 years, alongside a 34.4% decline year to date...